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Abstract
Background: The usefulness of high-sensitivity troponin T (hs-TnT) as a predictor of sudden cardiac 
arrest (SCA) in patients undergoing valve surgery is currently unknown. 
Methods: A prospective study was conducted on a group of 815 consecutive patients with significant 
valvular heart disease that underwent elective valve surgery. The primary end-point was postoperative SCA.
Results: The postoperative SCA occurred in 26 patients. At multivariate analysis of hs-TnT measured 
immediately after surgery (hs-TnT I) and age remained independent predictors of the primary end-point. 
Conclusions: Elevated postoperative hs-TnT was associated with a higher risk of postoperative SCA. 
(Cardiol J 2019; 26, 6: 777–781)
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Introduction
Postoperative sudden cardiac arrest (SCA) 
is a complication which significantly increases 
the risk of hospital death as well as the length of 
hospital stay. The diagnosis of SCA can be made 
if the cardiac arrest occurs within an hour of the 
onset of acute symptoms and has been reversed or 
not been reversed by ongoing resuscitation. Sud-
den cardiac arrest usually occurs in the course of 
cardiac arrhythmias such as ventricular fibrillation, 
ventricular tachycardia, pulseless electrical activ-
ity or asystole. The reasons for sudden arrest are 
different in younger people than in older people. 
Young people are dominated by canalopathies and 
cardiomyopathies. Chronic degenerative diseases 
such as coronary heart disease, valvular heart 
disease and heart failure are prevalent in older 
populations [1–5]. Predictors of SCA include left 
ventricular ejection fraction (LVEF), programmed 
ventricular stimulation, QT interval dispersion, 
late potentials, heart rate variability, microvolt 
T-wave alternans, baroreflex sensitivity and heart 
rate turbulence [6, 7]. Among emerging variables 
that look promising for predicting sudden cardiac 
death are biochemical indicators such as the B-type 
natriuretic peptide and N-terminal pro-B-type 
natriuretic peptide, which have shown encouraging 
results in preliminary investigations [1].
Troponin T (TnT) is a polypeptide that is 
part of the striated contractile muscle apparatus. 
A very important aspect from a diagnostic point of 
view is the fact that the sequence of troponins of 
cardiac origin differs from the sequence of skeletal 
troponins. Thanks to this, after obtaining specific 
monoclonal antibodies, it became possible to use 
them in the diagnosis of ischemia and hypoxia of 
cardiomyocytes [8]. In the available literature, nu-
merous articles describe high sensitivity troponin 
T (hs-TnT) as a biomarker of predictive importance 
in various diseases of the cardiovascular system, 
such as heart failure, coronary artery disease 
(CAD) and aortic stenosis [9–13]. The usefulness 
of the hs-TnT as a predictor of perioperative SCA 
in patients with valve disease undergoing valve 
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Methods
The current prospective study was performed 
on consecutive patients with hemodynamically 
significant valve defects (aortic stenosis, aortic 
regurgitation, mitral stenosis and mitral regurgita-
tion) who underwent elective replacement or repair 
of the valve. The exclusion criteria were: patients 
under 18 years of age, a lack of consent to partici-
pate in the study, autoimmune diseases, chronic 
inflammatory bowel, active neoplastic diseases and 
active infective endocarditis.
Complete blood count was performed with 
K2-EDTA samples, using a Cobas 6000 electronic 
counter (Roche, Mannheim, Germany). The day 
before surgery, immediately after patient arrival 
at the intensive care clinic after surgery and one 
day after operation, a blood sample for hs-TnT was 
collected from each patient. The plasma levels of 
cardiac TnT (cTnT) concentrations were measured 
by the troponin T hs-STAT (Roche). 
All procedures were performed through a mid-
line sternotomy incision under general anesthesia 
in a normothermia. All patients were given cold 
blood cardioplegia at the initial dose of 15–20 mL/kg 
followed by booster doses of 5–10 mL/kg every 
20 min. The primary end-point at intra-hospital 
follow-up was postoperative SCA defined as cardiac 
arrest within an hour of the onset of acute symp-
toms and has been reversed or not reversed by on-
going resuscitation. Patients were followed up for 
30 days or until death. The follow-up of discharged 
patients was conducted through direct observation 
during hospitalization and clinic visits 30 days after 
surgery. The study was conducted at the Institute 
of Cardiology, Warsaw, between 1 January 2014 and 
20 September 2018. The protocol was approved by 
the Institutional Ethics Committee.
Statistical analysis
A statistical analysis was performed using the 
SAS version 9.2. Data are presented as the mean 
± standard deviation and the frequency (%). In-
tergroup comparisons were made using the Mann-
Whitney U test, the Pearson c2 test or Student 
t-test. The Shapiro-Wilk test of normality was used 
to test the sample distribution. Logistic regression 
was used to assess relationships between variables. 
The following covariates: age, aortic cross-clamp 
time, cardiopulmonary bypass time, atrial fibrilla-
tion, body mass index, chronic obstructive airway 
disease, CAD, coronary artery bypass grafting 
(CABG) procedure, creatinine, hs-TnT, hemo-
globin, hypertension, left ventricular end-diastolic 
and end-systolic diameters, LVEF, New York Heart 
Association classes, peripheral atherosclerosis, 
pulmonary blood pressure, tricuspid annulus plane 
systolic excursion, high-sensitivity troponin T 
measured immediately after surgery (hs-TnT I) 
and high-sensitivity troponin T measured 1 day 
after operation (hs-TnT II) were investigated for 
association with endpoints in univariate analysis. 
Significant determinants (p < 0.05) identified from 
univariate analysis were subsequently entered into 
multivariate models. The Spearman rank correla-
tion coefficient was used to search for associations 
between the postoperative serum hs-TnT level and 
cardiopulmonary bypass time, aortic cross-clamp 
time. Predictive value of hs-TnT I was assessed 
by a comparison of the areas under the receiver 
operator characteristics of the respective curve. On 
the basis of the Youden index, a cut-off point was 
determined that met with the criterion of maximum 
sensitivity and specificity for perioperative SCA. 
Results
The study included 815 patients who un-
derwent heart valve surgery with or without 
concomitant procedures. The mean age in the 
study group was 64 ± 13. Sixty-three (7.7%) pa-
tients had significantly impaired left ventricular 
systolic function (LVEF ≤ 35%). The mean preop-
erative hs-TnT level was 35 ± 29 ng/L, hs-TnT I 
level was 925 ± 802 ng/L and hs-TnT II level was 
1321 ± 1103 ng/L. Table 1 shows the characteris-
tics of the patients studied. A postoperative SCA 
occurred in 26 patients (ventricular fibrillation 
11 patients, ventricular tachycardia 6 patients, 
pulseless electrical activity 3 patients and asystole 
6 patients). In all patients with SCA resuscitation was 
initiated, which resulted in the restoration of hemo-
dynamically stable cardiac rhythm in 18 patients. In 
8 (1%) patients, cardiopulmonary resuscitation 
was ineffective. During further follow-up, in an-
other 8 patients after SCA, death occurred due 
to gradually increasing multi-organ failure. The 
statistically significant predictors of postopera-
tive SCA at univariate analysis are presented in 
Table 2. At multivariate analysis hs-TnT I (odds 
ratio [OR] 1.304, 95% confidence interval [CI] 
1.201–1.409; p = 0.004), and age (OR 1.059; 95% 
CI 1.013–1.108; p = 0.01) remained independent 
predictors of the primary end-point. The area 
under receiver operator characteristic curve for 
postoperative SCA for hs-TnT I is 0.776 (95% CI 
0.702–0.850; Fig. 1). The total mortality in the 30-
-day follow-up was 4.4%. The main cause of death 
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in the post-operative period was gradually increas-
ing multiple organ dysfunction syndrome. In the 
subgroup of 115 patients with concomitant CAD, 
an additional CABG procedure was performed in 
111 patients, while in the postoperative period 
4 patients experienced SCA. At univariate analysis 
CAD (p = 0.21) and the additional CABG procedure 
(p = 0.2) were not predictors of SCA in the early 
postoperative period. Patients with concomitant 
CAD did not have significantly higher hs-TnT I 
levels (p = 0.35) compared with patients without 
CAD. In the postoperative period 63 patients ex-
perienced acute kidney injury (AKI). Patients with 
postoperative AKI did not have significantly higher 
hs-TnT I levels (p = 0.36) compared with patients 
Table 1. Baseline characteristics of the study 
population (n = 815).
Parameters Values
Preoperative characteristics of patients 
Age [year] 64 ± 13
Atrial fibrillation 350 (42%)
Body mass index [kg/m2] 27 ± 9
Coronary artery disease 115 (14%)
Chronic kidney disease  
(GFR < 60 mL/min/1.73 m2)
250 (31%)
COAD 53 (7%)
Creatinine [mg/dL] 0.9 ± 0.5
Hemoglobin [g/dL] 13.6 ± 1.5
LVEF [%] 57 ± 12
Male: men 470 (57%)
NYHA classes 2.5 ± 0.5
Peripheral atherosclerosis 135 (16%)
Hs-TnT [ng/L] 35 ± 29
Intraoperative characteristics of patients 
Aortic cross-clamp time [min] 95 ± 39
Cardiopulmonary bypass time [min] 123 ± 52
Lactates [mmol/L] 1.6 ± 0.5
Ph 7.4 ± 0.1
Postoperative characteristics of patients 
Hs-TnT I [ng/L] 925 ± 802
Hs-TnT II [ng/L] 1321 ± 1103
Creatinine II [mg/dL] 1.4 ± 0.4
Hemoglobin II [g/dL] 10.2 ± 1.5
The day of SCA [days] 2 ± 1.5
Main procedures
AVR 411 (50%)





Aortic surgery 166 (20%)
CABG 111 (14%)
TVP 179 (22%)
Values are represented by the mean and a measure of the variation 
of the internal standard deviation. AVP — aortic valve plasty; AVR — 
aortic valve replacement; CABG — coronary artery bypass grafting; 
COAD — chronic obstructive airways disease; Creatinine II —  
creatinine measured one day after operation; GFR — glomerular 
filtration rate; Hemoglobin II — hemoglobin measured one day 
after operation; Hemoglobin — hemoglobin measured one day 
before operation; Hs-TnT I — high-sensitivity troponin T measured 
immediately after surgery; Hs-TnT II — high-sensitivity troponin T 
measured one day after operation; LVEF — left ventricular ejection 
fraction; MVP — mitral valve plasty; MVR —  mitral valve replace-
ment; NYHA — New York Heart Association; SCA — sudden  
cardiac arrest; TVP — tricuspid valve plasty
Table 2. Analysis of predictive factors for the  
occurrence of postoperative sudden cardiac arrest.
Variable  Odds ratio 95% Cl P
Age [years] 1.050 1.008–1.095 0.01
LVEF [%] 0.971 0.944–0.998 0.04
NYHA [classes] 2.377 1.173–4.815 0.01
Hs-TnT I [ng/L] 1.211 1.106–1.326 0.001
CI — confidence interval; Hs-TnT I — high-sensitivity troponin T 
measured immediately after surgery; LVEF — left ventricular  
ejection fraction; NYHA — New York Heart Association
Figure 1. Area under receiver operating characteristic 
curve of high-sensitivity troponin T measured immedi-
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without AKI, but patients with postoperative AKI 
had significantly higher hs-TnT II levels (p = 0.02) 
compared to patients without AKI. A positive cor-
relation was found between the level of hs-TnT II 
and aortic cross-clamp time (r = 0.35; p = 0.005) 
as well as between the level of hs-TnT II and car-
diopulmonary bypass time (r = 0.47; p = 0.0001), 
but wasn’t found between the level of hs-TnT I 
and aortic cross-clamp time (p = 0.1) or cardio-
pulmonary bypass time (p = 0.12). At univariate 
analysis hs-TnT II (p = 0.09), aortic cross-clamp 
time (p = 0.13) and cardiopulmonary bypass time 
(p = 0.11) were not predictors of postoperative 
SCA. The mean preoperative value of LVEF in the 
group of patients with SCA was 44% ± 15% and 
was significantly lower compared to patients with 
no SCA 58% ± 10% (p = 0.01).  
Discussion
Postoperative SCA is a serious complication in 
patients undergoing heart valve surgery and is as-
sociated with very high mortality. The present paper 
demonstrated the prognostic significance of hs-TnT I 
in predicting SCA in the early postoperative period 
in patients undergoing heart valve surgery.
Currently, it is believed that cTnT is the best 
laboratory parameter in the diagnosis of myocardial 
injury. Considering the fact that the cytoplasm of 
cardiomyocytes contains a small amount of free 
TnT, even small damage to the cell membrane 
causes their release and the possibility of detection 
in the blood sample under investigation. Therefore, 
TnT detected in plasma is a highly specific marker 
of myocardial injury [14–16]. To date, numer-
ous publications have demonstrated a significant 
relationship between higher troponin values and 
worse prognosis in patients with acute myocardial 
infarction, heart failure or severe aortic valve dis-
ease [9–13]. It has also been described that TnT is 
a predictor of cardiac death in patients with CAD, 
atrial fibrillation or impaired left ventricular func-
tion [17–21]. However, Rahimi et al. [22] did not 
show a significant correlation between postmortem 
TnT level and sudden death. 
Significant heart valve defects are often result 
in a volume or pressure overload of the heart cavi-
ties. It is worth noting that, a long-lasting additional 
burden on the myocardium causes progressive 
degenerative changes of the myocardium, which 
are accompanied by slow processes of necrosis 
and fibrosis [23–25]. According to some research-
ers, increased values of postoperative troponin 
level are associated with increased permeability 
of the cell membrane after myocardial reperfusion 
[26]. However, Opfermann et al. [27] did not find 
a linear correlation between maximum values of 
the postoperative TnT and ejection fraction, left 
ventricular hypertrophy, operating time, cardiopul-
monary bypass time, time of cardiac arrest, lowest 
body temperature, perfusion pressure, cardioplegia 
volume, reperfusion time, or ventilation time [27]. 
In the present study, on a group of 815 patients 
undergoing heart valve surgery only hs-TnT I was 
an independent predictor postoperative SCA. The 
presented study did not show a significant correla-
tion between the value of hs-TnT I and the length 
of aortic clamping time as well as extracorporeal 
circulation time. Moreover, patients with postop-
erative SCA were shown to have significantly lower 
preoperative LVEF compared with patients without 
SCA. This may suggest that higher values of TnT 
in the very early postoperative period are associ-
ated with the severity of preoperative damage to 
the myocardium resulting from cardiac valvular 
disease and increased permeability of hs-TnT 
across the cell membrane after myocardial reperfu-
sion. Moreover, the higher values of hs-TnT  I may 
indicate a seriously damaged myocardium which is 
susceptible to the occurrence of life-threatening 
heart rhythm disturbances that may lead to SCA. 
It is worth noting that of the 26 patients who ex-
perienced SCA, up to 16 patients had a maximum 
30-day period before death.
Conclusions 
Sudden cardiac arrest occurs in the course of 
cardiac arrhythmias. Troponin T is a polypeptide 
that is part of the striated contractile muscle appa-
ratus, moreover it is the best laboratory parameter 
in the diagnosis of myocardial injury. The results 
of this study indicate that troponin T measured 
immediately after surgery is a predictor of SCA in 
the early postoperative period in patients undergo-
ing heart valve surgery. Further study is needed to 
clarify the pathomechanisms linking an increased 
risk of SCA in patients with a higher hs-TnT in 
the early postoperative period. Enlargement of the 
number of participants may allow for confirmation 
of results obtained. The results of this research 
may be helpful in perioperative strategy for pa-
tients undergoing heart valve surgery. 
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